Evidence map›Paper›PMID 33754124›Full record

ReviewBeni-Suef University journal of basic and applied sciences2021

COVID-19 pandemic: the implications of the natural history, challenges of diagnosis and management for care in sub-Saharan Africa.

Lawrence Omo-Aghoja, Emuesiri Goodies Moke, Kenneth Kelechi Anachuna, Adrian Itivere Omogbiya, Emuesiri Kohworho Umukoro, Pere-Ebi Yabrade Toloyai, Tarela Melish Elias Daubry, Anthony Taghogho Eduviere

Abstract readReview
In one paragraph

Review in Beni-Suef University journal of basic and applied sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lawrence Omo-AghojaDELSU Biomedical Research Alliance Working Group, College of Health Sciences, Delta State University, Abraka, Nigeria.ORCID 0000-0002-0569-3040
Emuesiri Goodies MokeDELSU Biomedical Research Alliance Working Group, College of Health Sciences, Delta State University, Abraka, Nigeria.
Kenneth Kelechi AnachunaDELSU Biomedical Research Alliance Working Group, College of Health Sciences, Delta State University, Abraka, Nigeria.
Adrian Itivere OmogbiyaDELSU Biomedical Research Alliance Working Group, College of Health Sciences, Delta State University, Abraka, Nigeria.
Emuesiri Kohworho UmukoroDELSU Biomedical Research Alliance Working Group, College of Health Sciences, Delta State University, Abraka, Nigeria.
Pere-Ebi Yabrade ToloyaiDELSU Biomedical Research Alliance Working Group, College of Health Sciences, Delta State University, Abraka, Nigeria.
Tarela Melish Elias DaubryDELSU Biomedical Research Alliance Working Group, College of Health Sciences, Delta State University, Abraka, Nigeria.
Anthony Taghogho EduviereDELSU Biomedical Research Alliance Working Group, College of Health Sciences, Delta State University, Abraka, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease (COVID-19) is a severe acute respiratory infection which has afflicted virtually almost all nations of the earth. It is highly transmissible and represents one of the most serious pandemics in recent times, with the capacity to overwhelm any healthcare system and cause morbidity and fatality. MAIN CONTENT: The diagnosis of this disease is daunting and challenging as it is dependent on emerging clinical symptomatology that continues to increase and change very rapidly. The definitive test is the very expensive and scarce polymerase chain reaction (PCR) viral identification technique. The management has remained largely supportive and empirical, as there are no officially approved therapeutic agents, vaccines or antiviral medications for the management of the disease. Severe cases often require intensive care facilities and personnel. Yet there is paucity of facilities including the personnel required for diagnosis and treatment of COVID-19 in sub-Saharan Africa (SSA). It is against this backdrop that a review of key published reports on the pandemic in SSA and globally is made, as understanding the natural history of a disease and the documented responses to diagnosis and management is usually a key public health strategy for designing and improving as appropriate, relevant interventions. Lead findings were that responses by most nations of SSA were adhoc, paucity of public health awareness strategies and absence of legislations that would help enforce preventive measures, as well as limited facilities (including personal protective equipment) and institutional capacities to deliver needed interventions.

conclusionCOVID-19 is real and has overwhelmed global health care system especially low-income countries of the sub-Sahara such as Nigeria. Suggestions for improvement of healthcare policies and programs to contain the current pandemic and to respond more optimally in case of future pandemics are made herein.

Indexed as

COVID-19ManagementNatural historyNigeriaRespiratory infection

Identifiers

PMID33754124
PMCPMC7968562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.